VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies. (2019)

First Author: Beaton L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2196/13696

PubMed Identifier: 31579027

Publication URI: http://europepmc.org/abstract/MED/31579027

Type: Journal Article/Review

Volume: 8

Parent Publication: JMIR research protocols

Issue: 10

ISSN: 1929-0748